U.S. markets closed

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
147.44+2.69 (+1.86%)
At close: 1:02PM EST
Sign in to post a message.
  • R
    Ray
    $GILD conversation
    Okay so, $LLY adds 4B to their market cap with a 375 million dollar deal and emergency approval.

    Gilead has lost 5B in market cap after full approval and 900 million in sales.

    Excuse me but what is going on here?
    Bullish
  • R
    Rajesh
    End of the day when all dust has settled you and I will see that only LLY and REGN antibody therapy works as a cure and treatment. A real vaccine against COVID-19 is impossible.
  • G
    Guy S
    Eli has vaccine prices in, even though its highly unlikely to be viable/successful... careful here guys as this could drop like a rock.
  • H
    Hulk
    Sorry everyone, i left the TD Ameritrade app open and my kid bought about 2 million shares of LLY. It’s ok now.
  • y
    yandt
    Anyone know how to increase the size of the font on these conversations without having to increase your iphone font?
  • A
    Abraham
    $ENZC

    Under "right to try" & "compassionate use" laws, $ENZC's "CLONE 3"/"proprietary mAbs production methodology" should go straight to Clinical Trials to help later-stage patients, especially those who need help breathing.

    $LLY $REGN recently paused mAbs trials for late stage
  • w
    warren
    ✅🤑👍 NEWS: HUGE BUYERS COMING Aptinyx Inc (NASDAQ:APTX) major shareholder Bain Capital Life Sciences Inv acquired 3,333,333 shares of the firm’s stock in a transaction that occurred on Monday, October 26th. The stock was purchased at an average price of $3.00 per share, with a total value of $9,999,999.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.$PFE and $LLY could and should look into this NOW IMO. Meanwhile I’m buying all three
  • B
    Benji
    Didn’t this drug just fail trials 2 weeks ago?!
  • B
    Beverly
    I am highly encouraged in the potential outcomes of clinical trials on antibody treatment of covid-19
    Bullish
  • S
    Simon
    Enzolytics Inc.
    mAbs can be used to fight #Cancer. Dr. Cotropia $ENZC already has the patent for monoclonal antibodies. This is a truly amazing. So many people are going to be able get the meds they need. $ENZC is going to be the game changer. $JnJ $LLY

    @JNJNews
    Bullish
  • S
    Simon
    Enzolytics Inc.


    Uncle Billy McBride

    @UncleBillyMoney

    ·

    25m

    BIG NEWS $LLY 1st to market w MONOCLONAL ANTIBODY via Emergency Use Authorization $ENZC confirmed talks w $LLY in last PR & CEO provided roadmap to improve as virus mutates $LLY mAbs won't be for late stage (that trial paused) $LLY know #CLONE3 works via prior research collab
    Bullish
  • S
    Simon
    Enzolytics Inc.
    Conversation



    Uncle Billy McBride

    @UncleBillyMoney

    BIG NEWS $LLY 1st to market w MONOCLONAL ANTIBODY via Emergency Use Authorization $ENZC confirmed talks w $LLY in last PR & CEO provided roadmap to improve as virus mutates $LLY mAbs won't be for late stage (that trial paused) $LLY know #CLONE3 works via prior research collab









    Quote Tweet



    Mike

    @crabbermike

    · 2h

    $LLY $ENZC The FDA just authorized Eli Lilly's antibody treatment for emergency use to treat the coronavirus https://businessinsider.com/eli-lilly-covid-antibody-treatment-authorized-emergency-use-trump-coronavirus-2020-10?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter… via @businessinsider
    The company's antibody treatment is similar to the one President Donald Trump received in the hospital.
    The company's antibody treatment is similar to the one President Donald Trump received in the hospital.
    businessinsider.com
  • J
    JB
    LLY doing very well on election results! A nice Biden win (78% chance right now) and Republican Senate (91% chance right now) after all is sad and done - that's great for LLY. It means divided government, which give big pharma more room to profit without government interference. It also means Trump is likely gone (so say goodbye to his efforts to lower drug prices). Biden is more easily lobbied and likely responds more to special interest money (especially without a "blue wave" mandate for "change" and less pressure form progressives). This election just delivered a "RETURN TO STATUS QUO" result. Soft (legal) corruption and influence peddling will continue apace. Buy big tech and Big Pharma and GET REWARDED. Workers in the US are the losers here, without Trump. Look for cheap immigrant labor flows to increase and for pharma price gouging, job / manufacturing outsourcing, Chinese influence, etc. to also increase. The rich get richer and workers get poorer, at least for the next 4 years. Corporate profits up, threading the needle between avoiding both regulation and also Biden's tax plans, as Senate will block big moves. Governing by "executive order" to continue. No one is going to be there to stop China or big tech from taking over the World.
  • R
    Ray
    $GILD conversation
    $LLY up 3% on emergency approval and their market cap is double Gilead.

    Are you guys starting to see how manipulated this stock is? We should be $85 at an absolute minimum.
    Bullish
  • B
    Beverly
    Lilly is one powerful company and I feel great regarding this long term holdings and investment.
    Bullish
  • D
    DakineLuth
    Baricitinib EUA!!!!
  • A
    Anonymous
    Strange, FDA rejected BIIB. Its stock is halted. LLY dropped $5 as sympathy.
  • R
    R
    LLY's price has nothing to do with Covid-19. It never did. Covid-19 cocktail was a bonus if approved. It's all about growth and earnings. They will beast earnings and the projected growth is around 18%. Stock will jump one day to $168 like it did on Oct 9th. The bear trap is set.
    Bullish
  • I
    Ian Beninger
    Okay so LLY showed no success with hospitalized patients in their antibody treatment. Neither did regeneron and the reason is that by that point, it is too late. But my feeling is that if either of those two treatments is started early in the infection process as what happened with Trump, they are quite efficient at stopping the infection. So the market for this drug in my opinion is people recently diagnosed that are in a high-risk category. I am hoping that my prediction comes true of course because I hold LLY stock.
    Neutral
  • M
    Mikael
    Drug fails and then gets approved. Corruption apex